NYSE:XTNT
Xtant Medical Holdings, Inc.
Xtant Medical Holdings, Inc.'s revenue grew 14.2% in fiscal 2025 to $133.9M while operating margin rose to 5.4%, its highest in 10 years. Free cash flow was $10.2M, 7.6% of revenue, and the diluted share count rose 12.3%.Summary generated from Xtant Medical Holdings, Inc.'s SEC filings. Latest annual report filed Mar 31, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$133.9M
Revenue growth+14.2%
Revenue, 5-yr CAGR+20.2%
Gross margin62.9%
Operating margin5.4%
Net margin3.7%
ROIC10.0%
Return on equity10.6%
Debt / equity0.22
Free cash flow$10.2M
FCF margin7.6%
Share count change+12.3%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 55 | 58 | 91 | 117 | 134 |
| Operating income | −4 | −7 | −10 | −12 | 7 |
| Net income | −5 | −8 | 1 | −16 | 5 |
| Free cash flow | −2 | −7 | −11 | −16 | 10 |
Recent filings
- 4Insider transaction report
Aug 18, 2026 - 4Insider transaction report
Aug 18, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 11, 2026 - 8-KResults of operations and financial condition
Aug 11, 2026 - 8-KResults of a shareholder vote
Aug 7, 2026 - DEF 14AProxy statement
Jun 23, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 13, 2026 - 8-KResults of operations and financial condition
May 13, 2026